慢性阻塞性肺疾病患者雾化吸入治疗的临床分析
|
摘要
目的:研究慢性阻塞性肺疾病利用雾化吸入进行治疗的临床分析。方法:选取2015年3~11月在河南省直第一医院就诊的慢性阻塞性肺疾病患者70例,随机分为观察组和对照组各35例。对照组行常规治疗方案;观察组加用盐酸氨溴索雾化吸入。观察记录两组治疗前后的PaCO_2、PaO_2和SpO_2的变化情况,比较两组治疗的总有效率。结果:治疗7d后,两组PaCO_2、PaO_2和SpO_2水平较治疗前均有显著改善,观察组的血气指标明显好于对照组,差异具有统计学意义(P<0.05);观察组的总有效率91.4%,明显优于对照组的74.3%,差异有统计学意义(X2=9.2050,P=0.0104)。结论:对慢性阻塞性肺疾病患者进行雾化吸入治疗的临床效果良好,可以有效改善心肺功能,较好地缓解症状,值得推广。
Objective to study the chronic obstructive pulmonary disease with atomization inhalation treatment of clinical analysis method selection in March 2015 to November 2015 in our hospital 70 cases of patients with chronic obstructive pulmonary disease,were randomly divided into experimental group and control group of 35 cases control experiment. Observation group routine treatment plan;The control group was also inhaled with ambroxol hydrochloride. To observe the changes of PaCO_2,PaO_2 and SpO_2 before and after treatment of two groups of patients,the total effective rate of treatment was compared between the two groups. Results 7 d after treatment,two groups of patients with PaCO_2,PaO_2 and SpO_2 levels before the treatment were improved significantly,and blood gas index of observation group was obviously better than the control group,the difference is statistically significant(P <0.05); The total effective rate of observation group was 91.4%,significantly better than the total effective rate of 74.3% in the control group,and the difference was statistically significant(X2=9.2050,P=0.0104). Conclusion aerosol inhalation therapy in patients with chronic obstructive pulmonary disease clinical effect is good,can effectively improve the patients' cardiopulmonary function,to alleviate the patient's symptoms,is worth popularization and application widely.
Objective to study the chronic obstructive pulmonary disease with atomization inhalation treatment of clinical analysis method selection in March 2015 to November 2015 in our hospital 70 cases of patients with chronic obstructive pulmonary disease,were randomly divided into experimental group and control group of 35 cases control experiment. Observation group routine treatment plan;The control group was also inhaled with ambroxol hydrochloride. To observe the changes of PaCO_2,PaO_2 and SpO_2 before and after treatment of two groups of patients,the total effective rate of treatment was compared between the two groups. Results 7 d after treatment,two groups of patients with PaCO_2,PaO_2 and SpO_2 levels before the treatment were improved significantly,and blood gas index of observation group was obviously better than the control group,the difference is statistically significant(P <0.05); The total effective rate of observation group was 91.4%,significantly better than the total effective rate of 74.3% in the control group,and the difference was statistically significant(X2=9.2050,P=0.0104). Conclusion aerosol inhalation therapy in patients with chronic obstructive pulmonary disease clinical effect is good,can effectively improve the patients' cardiopulmonary function,to alleviate the patient's symptoms,is worth popularization and application widely.
引文
[1]赵焕,石寒冰,毕红霞,等.布地奈德联合福莫特罗雾化吸入治疗慢性阻塞性肺疾病的临床疗效观察[J].中国全科医学,2013,15(35):4219-4221.
[2]董睿,张连莲,刘颖,等.雾化吸入异丙托溴铵治疗慢性阻塞性肺疾病急性加重期的疗效[J].中国老年学杂志,2013,33(22):5587-5588.
[3]潘莉.联合雾化吸入治疗老年AECOPD患者的临床疗效及高危因素分析[J].中国老年学杂志,2014,34(9):2576-2577.
[4]刘德义,马胜喜,刘雨婷,等.不同雾化吸入方式在慢性阻塞性肺疾病肺部感染患者中的应用[J].中华医院感染学杂志,2014,24(14):3487-3489.
[5]马容莉.布地奈德联合复方异丙托溴铵雾化吸入治疗超高龄慢性阻塞性肺疾病急性加重患者的临床疗效[J].武汉大学学报(医学版),2014,35(6):925-927,951.
[6]张春美,丁震,裴翀,等.无创机械通气联合经管道雾化吸入布地奈德治疗AECOPD合并Ⅱ型呼吸衰竭的疗效[J].实用医学杂志,2015,11(5):819-820.
[7]朱越燕,张孝钦,薛骞,等.喘可治雾化治疗COPD急性发作期疗效观察[J].中药材,2015,38(4):875-877.
[8]郑乐贵,戴元荣,徐显,等.头孢哌酮舒巴坦联合雾化吸入治疗慢性阻塞性肺疾病患者急性加重期的疗效及对肺功能的影响[J].中国生化药物杂志,2016,36(1):86-88.
[2]董睿,张连莲,刘颖,等.雾化吸入异丙托溴铵治疗慢性阻塞性肺疾病急性加重期的疗效[J].中国老年学杂志,2013,33(22):5587-5588.
[3]潘莉.联合雾化吸入治疗老年AECOPD患者的临床疗效及高危因素分析[J].中国老年学杂志,2014,34(9):2576-2577.
[4]刘德义,马胜喜,刘雨婷,等.不同雾化吸入方式在慢性阻塞性肺疾病肺部感染患者中的应用[J].中华医院感染学杂志,2014,24(14):3487-3489.
[5]马容莉.布地奈德联合复方异丙托溴铵雾化吸入治疗超高龄慢性阻塞性肺疾病急性加重患者的临床疗效[J].武汉大学学报(医学版),2014,35(6):925-927,951.
[6]张春美,丁震,裴翀,等.无创机械通气联合经管道雾化吸入布地奈德治疗AECOPD合并Ⅱ型呼吸衰竭的疗效[J].实用医学杂志,2015,11(5):819-820.
[7]朱越燕,张孝钦,薛骞,等.喘可治雾化治疗COPD急性发作期疗效观察[J].中药材,2015,38(4):875-877.
[8]郑乐贵,戴元荣,徐显,等.头孢哌酮舒巴坦联合雾化吸入治疗慢性阻塞性肺疾病患者急性加重期的疗效及对肺功能的影响[J].中国生化药物杂志,2016,36(1):86-88.